China Biologics and Biosimilars Market Research Report 2016

China Biologics and Biosimilars Market Research Report 2016

1 Biologics and Biosimilars Market Overview

1.1 Product Overview and Scope of Biologics and Biosimilars

1.2 Biologics and Biosimilars Segment by Type

1.2.1 China Production Market Share of Biologics and Biosimilars Type in 2015

1.2.2 Biologics

1.2.3 Biosimilars

1.2.4 Type III

1.3 Applications of Biologics and Biosimilars

1.3.1 Biologics and Biosimilars Consumption Market Share by Application in 2015

1.3.2 Tumor

1.3.3 Diabetes

1.3.4 Cardiovascular

1.3.5 Others

1.4 China Market Size (Value) of Biologics and Biosimilars (2011-2021)

1.5 China Biologics and BiosimilarsStatus and Outlook

1.6 Government Policies

2 China Biologics and Biosimilars Market Competition by Manufacturers

2.1 China Biologics and Biosimilars Capacity, Production and Share by Manufacturers (2015 and 2016)

2.2 China Biologics and Biosimilars Revenue and Share by Manufacturers (2015 and 2016)

2.3 China Biologics and Biosimilars Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Biologics and Biosimilars Manufacturing Base Distribution, Sales Area, Product Type

2.5 Biologics and Biosimilars Market Competitive Situation and Trends

2.5.1 Biologics and Biosimilars Market Concentration Rate

2.5.2 Biologics and Biosimilars Market Share of Top 3 and Top 5 Manufacturers

3 China Biologics and Biosimilars Manufacturers Profiles/Analysis

3.1 Pfizer

3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.1.2 Biologics and Biosimilars Product Type, Application and Specification

3.1.2.1 Type I

3.1.2.2 Type II

3.1.3 Pfizer Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.1.4 Main Business/Business Overview

3.2 Roche

3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.2.2 119 Product Type, Application and Specification

3.2.2.1 Type I

3.2.2.2 Type II

3.2.3 Roche 119 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.2.4 Main Business/Business Overview

3.3 Amgen

3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.3.2 128 Product Type, Application and Specification

3.3.2.1 Type I

3.3.2.2 Type II

3.3.3 Amgen 128 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.3.4 Main Business/Business Overview

3.4 AbbVie

3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.4.2 Nov Product Type, Application and Specification

3.4.2.1 Type I

3.4.2.2 Type II

3.4.3 AbbVie Nov Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.4.4 Main Business/Business Overview

3.5 Sanofi

3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.5.2 Product Type, Application and Specification

3.5.2.1 Type I

3.5.2.2 Type II

3.5.3 Sanofi Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.5.4 Main Business/Business Overview

3.6 Johnson & Johnson

3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.6.2 Million USD Product Type, Application and Specification

3.6.2.1 Type I

3.6.2.2 Type II

3.6.3 Johnson & Johnson Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.6.4 Main Business/Business Overview

3.7 Novo Nordisk

3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.7.2 Commodities Product Type, Application and Specification

3.7.2.1 Type I

3.7.2.2 Type II

3.7.3 Novo Nordisk Commodities Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.7.4 Main Business/Business Overview

3.8 Novartis

3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.8.2 Product Type, Application and Specification

3.8.2.1 Type I

3.8.2.2 Type II

3.8.3 Novartis Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.8.4 Main Business/Business Overview

4 China Biologics and Biosimilars Capacity, Production, Revenue, Consumption, Export and Import (2011-2016)

4.1 China Biologics and Biosimilars Capacity, Production and Growth (2011-2016)

4.2 China Biologics and Biosimilars Revenue and Growth (2011-2016)

4.3 China Biologics and Biosimilars Production, Consumption, Export and Import (2011-2016)

5 China Biologics and Biosimilars Production, Revenue (Value) , Price Trend by Type

5.1 China Biologics and Biosimilars Production and Market Share by Type (2011-2016)

5.2 China Biologics and Biosimilars Revenue and Market Share by Type (2011-2016)

5.3 China Biologics and Biosimilars Price by Type (2011-2016)

5.4 China Biologics and Biosimilars Production Growth by Type (2011-2016)

6 China Biologics and Biosimilars Market Analysis by Application

6.1 China Biologics and Biosimilars Consumption and Market Share by Application (2011-2016)

6.2 China Biologics and Biosimilars Consumption Growth Rate by Application (2011-2016)

6.3 Market Drivers and Opportunities

6.3.1 Potential Application

6.3.2 Emerging Markets/Countries

7 Biologics and Biosimilars Manufacturing Cost Analysis

7.1 Biologics and Biosimilars Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Biologics and Biosimilars

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Biologics and Biosimilars Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 China Biologics and Biosimilars Market Forecast (2016-2021)

11.1 China Biologics and Biosimilars Capacity, Production, Revenue Forecast (2016-2021)

11.2 China Biologics and Biosimilars Production, Import, Export and Consumption Forecast (2016-2021)

11.3 China Biologics and Biosimilars Production Forecast by Type (2016-2021)

11.4 China Biologics and Biosimilars Consumption Forecast by Application (2016-2021)

11.5 Biologics and Biosimilars Price Forecast (2016-2021)

12 Research Findings and Conclusion

13 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

Figure Picture of Biologics and Biosimilars

Figure China Production Market Share of Biologics and Biosimilars by Type in 2015

Figure Product Picture of Biologics

Table Major Manufacturers of Biologics

Figure Product Picture of Biosimilars

Table Major Manufacturers of Biosimilars

Figure Product Picture of Type III

Table Major Manufacturers of Type III

Table Biologics and Biosimilars Consumption Market Share by Application in 2015

Figure Tumor Examples

Figure Diabetes Examples

Figure Cardiovascular Examples

Figure Others Examples

Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)

Table China Biologics and Biosimilars Capacity of Key Manufacturers (2015 and 2016)

Table China Biologics and Biosimilars Capacity Market Share of Key Manufacturers (2015 and 2016)

Figure China Biologics and Biosimilars Capacity of Key Manufacturers in 2015

Figure China Biologics and Biosimilars Capacity of Key Manufacturers in 2016

Table China Biologics and Biosimilars Production of Key Manufacturers (2015 and 2016)

Table China Biologics and Biosimilars Production Share by Manufacturers (2015 and 2016)

Figure 2015 Biologics and Biosimilars Production Share by Manufacturers

Figure 2016 Biologics and Biosimilars Production Share by Manufacturers

Table China Biologics and Biosimilars Revenue (Million USD) by Manufacturers (2015 and 2016)

Table China Biologics and Biosimilars Revenue Share by Manufacturers (2015 and 2016)

Table 2015 China Biologics and Biosimilars Revenue Share by Manufacturers

Table 2016 China Biologics and Biosimilars Revenue Share by Manufacturers

Table China Market Biologics and Biosimilars Average Price of Key Manufacturers (2015 and 2016)

Figure China Market Biologics and Biosimilars Average Price of Key Manufacturers in 2015

Table Manufacturers Biologics and Biosimilars Manufacturing Base Distribution and Sales Area

Table Manufacturers Biologics and Biosimilars Product Type

Figure Biologics and Biosimilars Market Share of Top 3 Manufacturers

Figure Biologics and Biosimilars Market Share of Top 5 Manufacturers

Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pfizer Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Biologics and Biosimilars Market Share (2011-2016)

Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Roche Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Roche Biologics and Biosimilars Market Share (2011-2016)

Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Amgen Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Amgen Biologics and Biosimilars Market Share (2011-2016)

Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table AbbVie Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure AbbVie Biologics and Biosimilars Market Share (2011-2016)

Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Sanofi Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Sanofi Biologics and Biosimilars Market Share (2011-2016)

Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Johnson & Johnson Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Johnson & Johnson Biologics and Biosimilars Market Share (2011-2016)

Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novo Nordisk Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Novo Nordisk Biologics and Biosimilars Market Share (2011-2016)

Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novartis Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis Biologics and Biosimilars Market Share (2011-2016)

Figure China Biologics and Biosimilars Capacity, Production and Growth (2011-2016)

Figure China Biologics and Biosimilars Revenue (Million USD) and Growth (2011-2016)

Table China Biologics and Biosimilars Production, Consumption, Export and Import (2011-2016)

Table China Biologics and Biosimilars Production by Type (2011-2016)

Table China Biologics and Biosimilars Production Share by Type (2011-2016)

Figure Production Market Share of Biologics and Biosimilars by Type (2011-2016)

Figure 2015 Production Market Share of Biologics and Biosimilars by Type

Table China Biologics and Biosimilars Revenue by Type (2011-2016)

Table China Biologics and Biosimilars Revenue Share by Type (2011-2016)

Figure Production Revenue Share of Biologics and Biosimilars by Type (2011-2016)

Figure 2015 Revenue Market Share of Biologics and Biosimilars by Type

Table China Biologics and Biosimilars Price by Type (2011-2016)

Figure China Biologics and Biosimilars Production Growth by Type (2011-2016)

Table China Biologics and Biosimilars Consumption by Application (2011-2016)

Table China Biologics and Biosimilars Consumption Market Share by Application (2011-2016)

Figure China Biologics and Biosimilars Consumption Market Share by Application in 2015

Table China Biologics and Biosimilars Consumption Growth Rate by Application (2011-2016)

Figure China Biologics and Biosimilars Consumption Growth Rate by Application (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Biologics and Biosimilars

Figure Manufacturing Process Analysis of Biologics and Biosimilars

Figure Biologics and Biosimilars Industrial Chain Analysis

Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015

Table Major Buyers of Biologics and Biosimilars

Table Distributors/Traders List

Figure China Biologics and Biosimilars Capacity, Production and Growth Rate Forecast (2016-2021)

Figure China Biologics and Biosimilars Revenue and Growth Rate Forecast (2016-2021)

Table China Biologics and Biosimilars Production, Import, Export and Consumption Forecast (2016-2021)

Table China Biologics and Biosimilars Production Forecast by Type (2016-2021)

Table China Biologics and Biosimilars Consumption Forecast by Application (2016-2021)